59 related articles for article (PubMed ID: 15515210)
21. Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.
Kantarjian H; O'Brien S; Cortes J; Giles F; Thomas D; Kornblau S; Shan J; Beth Rios M; Keating M; Freireich E; Talpaz M
Cancer; 2003 Jul; 98(1):81-5. PubMed ID: 12833459
[TBL] [Abstract][Full Text] [Related]
22. Philadelphia negative, Bcr-Abl positive chronic myeloid leukemia associated with pure red cell aplasia.
Karti S; Yilmaz M; Sonmez M; Akdogan R; Ersoz S; Ucar F; Ovali E
J Exp Clin Cancer Res; 2003 Jun; 22(2):341-2. PubMed ID: 12866588
[TBL] [Abstract][Full Text] [Related]
23. Significance of FHIT expression in chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; O'Brien S; Manshouri T; Cortes J; Giles F; Rios MB; Croce CM; Albitar M
Clin Cancer Res; 1999 Dec; 5(12):4059-64. PubMed ID: 10632340
[TBL] [Abstract][Full Text] [Related]
24. Unusual presentation of chronic myelogenous leukemia as multiple skin chloromas: report of a case with clinical and cytologic correlation.
Nagarajarao HS; Akhtar I; Heard K; Baliga M
Acta Cytol; 2009; 53(2):235-8. PubMed ID: 19365984
[TBL] [Abstract][Full Text] [Related]
25. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
26. [Hypercalcemia mediated by parathyroid hormone-related protein in the blastic phase of chronic myelogenous leukemia].
Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Tohda S; Koyama T; Murakami N; Miura O
Rinsho Ketsueki; 2002 Feb; 43(2):102-6. PubMed ID: 11925871
[TBL] [Abstract][Full Text] [Related]
27. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
Schultheis B; Pasternak G; Hehlmann R
Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
[TBL] [Abstract][Full Text] [Related]
28. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
29. Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML). Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT).
Martinelli G; Lemoli RM; Farabegoli P; Zaccaria A; Testoni N; Buzzi M; Fogli M; Visani G; Tosi P; Motta MR
Haematologica; 1994; 79(5):445-7. PubMed ID: 7531170
[TBL] [Abstract][Full Text] [Related]
30. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
31. Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles.
Ramos TL; Sánchez-Abarca LI; López-Ruano G; Muntión S; Preciado S; Hernández-Ruano M; Rosado B; de las Heras N; Chillón MC; Hernández-Hernández Á; González M; Sánchez-Guijo F; Del Cañizo C
Leuk Res; 2015 Aug; 39(8):921-4. PubMed ID: 26105049
[TBL] [Abstract][Full Text] [Related]
32. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
33. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
34. Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.
Oh SH; Park TS; Kim HR; Lee JY; Kim JH; Shin JH; Lee JN
Leuk Res; 2009 Nov; 33(11):e195-8. PubMed ID: 19446879
[TBL] [Abstract][Full Text] [Related]
35. [Renal and electrolyte disturbances in chronic myelogenous leukemia].
Kanno Y; Sakuyama M; Niitsu H; Ito T; Lee M; Ohtani H; Nakamoto Y; Miura A; Akihama T; Yamaguchi A
Rinsho Ketsueki; 1992 Sep; 33(9):1128-35. PubMed ID: 1433933
[TBL] [Abstract][Full Text] [Related]
36. Lymphoid blastic transformation in chronic myeloid leukemia.
Villegas A; González FA; López M; Armada B; Jordá J; Alarcón C
Am J Hematol; 1994 May; 46(1):58-9. PubMed ID: 8043098
[No Abstract] [Full Text] [Related]
37. Elastic properties of passive leukemic white blood cells.
Paulitschke M; Mikita J; Lerche D; Meier W
Int J Microcirc Clin Exp; 1991 Feb; 10(1):67-73. PubMed ID: 2019485
[TBL] [Abstract][Full Text] [Related]
38. Congenital acute myelogenous leukemia presenting as palpable renal masses in a neonate.
Butani L; Paulson TE
J Pediatr Hematol Oncol; 2003 Mar; 25(3):240-2. PubMed ID: 12621244
[TBL] [Abstract][Full Text] [Related]
39. Chronic Myelogenous Leukemia Presenting with Facial Nerve Palsy in an Infant.
Khajeh A; Miri Aliabad G; Fayyazi A; Soleimani G; Keikha R
Iran J Child Neurol; 2018; 12(3):122-125. PubMed ID: 30026776
[TBL] [Abstract][Full Text] [Related]
40. Acute kidney injury presenting a feature of leukemic infiltration during therapy for chronic myelogenous leukemia.
Yuzawa Y; Sato W; Masuda T; Hamada Y; Tatematsu M; Yasuda Y; Ozaki T; Ito I; Mizuno M; Maruyama S; Ito Y; Matsuo S
Intern Med; 2010; 49(12):1139-42. PubMed ID: 20558931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
